Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells
Authors:
Open Access
- 1 June 2014
- journal article
- research article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 28 (6) , 872-885
Abstract
In prostate cancer (PCa), the functional synergy between androgen receptor (AR) and nuclear factor-κ B (NF-κB) escalates the resistance to therapeutic regimens and promotes aggressive tumor growth. Although the underlying mechanisms are less clear, gene regulatory abilities of coactivators can bridge the transcription functions of AR and NF-κB. The present study shows that MYST1 (MOZ, YBF2 and SAS2, and TIP60 protein 1) costimulates AR and NF-κB functions in PCa cells. We demonstrate that activation of NF-κB promotes deacetylation of MYST1 by sirtuin 1. Further, the mutually exclusive interactions of MYST1 with sirtuin 1 vs AR regulate the acetylation of lysine 16 on histone H4. Notably, in AR-lacking PC3 cells and in AR-depleted LNCaP cells, diminution of MYST1 activates the cleavage of poly(ADP-ribose) polymerase and caspase 3 that leads to apoptosis. In contrast, in AR-transformed PC3 cells (PC3-AR), depletion of MYST1 induces cyclin-dependent kinase (CDK) N1A/p21, which results in G2M arrest. Concomitantly, the levels of phospho-retinoblastoma, E2F1, CDK4, and CDK6 are reduced. Finally, the expression of tumor protein D52 (TPD52) was unequivocally affected in PC3, PC3-AR, and LNCaP cells. Taken together, the results of this study reveal that the functional interactions of MYST1 with AR and NF-κB are critical for PCa progression.Keywords
This publication has 58 references indexed in Scilit:
- Molecular aspects of prostate cancerWorld Journal of Urology, 2012
- Androgen receptor co-activators in the regulation of cellular events in prostate cancerWorld Journal of Urology, 2011
- Androgen Action in Prostate CancerDiscover Oncology, 2010
- Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleusThe Prostate, 2009
- AR, the cell cycle, and prostate cancerNuclear Receptor Signaling, 2008
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer developmentOncogene, 2003
- Tip60 and Histone Deacetylase 1 Regulate Androgen Receptor Activity through Changes to the Acetylation Status of the ReceptorJournal of Biological Chemistry, 2002
- The Role of the Androgen Receptor in Prostate CancerCritical Reviews™ in Eukaryotic Gene Expression, 2002
- Tip60 Is a Nuclear Hormone Receptor CoactivatorJournal of Biological Chemistry, 1999